BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3516605)

  • 21. Acute fructose administration decreases the glycemic response to an oral glucose tolerance test in normal adults.
    Moore MC; Cherrington AD; Mann SL; Davis SN
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4515-9. PubMed ID: 11134101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects.
    Suter SL; Nolan JJ; Wallace P; Gumbiner B; Olefsky JM
    Diabetes Care; 1992 Feb; 15(2):193-203. PubMed ID: 1547676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes.
    Hawkins M; Gabriely I; Wozniak R; Vilcu C; Shamoon H; Rossetti L
    Diabetes; 2002 Mar; 51(3):606-14. PubMed ID: 11872657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The short-term effect of nicotinic acid on intermediary metabolism in insulin-dependent diabetes mellitus.
    Hale PJ; Nattrass M
    Ann Clin Biochem; 1991 Jan; 28 ( Pt 1)():39-43. PubMed ID: 2024932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.
    Gonzélez C; Stern MP; Mitchell BD; Valdez RA; Haffner SM; Pérez BA
    Diabetes Care; 1994 May; 17(5):397-404. PubMed ID: 8062606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal and metabolic profiles in patients with alcohol-induced, mixed hypertriglyceridemia before and after abstinence from ethanol and before and after a lipid-lowering diet.
    Lapolla A; Tessari P; Duner E; Trevisan R; Zordan V; Nosadini R; Tiengo A
    Atherosclerosis; 1986 May; 60(2):151-9. PubMed ID: 3718612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus.
    Chen YD; Swami S; Skowronski R; Coulston A; Reaven GM
    J Clin Endocrinol Metab; 1993 Jan; 76(1):172-7. PubMed ID: 8421086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meal frequency; does it determine postprandial lipaemia?
    Murphy MC; Chapman C; Lovegrove JA; Isherwood SG; Morgan LM; Wright JW; Williams CM
    Eur J Clin Nutr; 1996 Aug; 50(8):491-7. PubMed ID: 8863008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of oral glucose, fructose and saccharose loads on blood sugar, insulin and lipids in normal subjects].
    Ferlito S; Maugeri D; Lo Furno F; Calafato M
    Arch Sci Med (Torino); 1978; 135(4):447-60. PubMed ID: 756709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein A-IV levels and phenotype distribution in NIDDM.
    Vergès BL; Vaillant G; Goux A; Lagrost L; Brun JM; Gambert P
    Diabetes Care; 1994 Aug; 17(8):810-7. PubMed ID: 7956623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone.
    Kazumi T; Hirano T; Odaka H; Ebara T; Amano N; Hozumi T; Ishida Y; Yoshino G
    Diabetes; 1996 Jun; 45(6):806-11. PubMed ID: 8635657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of intravenous fructose and glucose on metabolism and plasma insulin levels in newborn infants.
    Pribylová H; Kimlová I; Stroufová A
    Biol Neonate; 1973; 23(3):205-13. PubMed ID: 4773527
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of BAYm 1099, new alpha-glucosidase inhibitor, on acute metabolic responses and metabolic control in NIDDM over 1 mo.
    Samad AH; Ty Willing TS; Alberti KG; Taylor R
    Diabetes Care; 1988 Apr; 11(4):337-44. PubMed ID: 3042310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic effects of dietary fructose in healthy subjects.
    Swanson JE; Laine DC; Thomas W; Bantle JP
    Am J Clin Nutr; 1992 Apr; 55(4):851-6. PubMed ID: 1550068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary fructose intolerance.
    Perheentupa J; Raivio KO; Nikkilä EA
    Acta Med Scand Suppl; 1972; 542():65-75. PubMed ID: 4579755
    [No Abstract]   [Full Text] [Related]  

  • 36. Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia.
    Yki-Järvinen H; Taskinen MR
    Diabetes; 1988 Sep; 37(9):1271-8. PubMed ID: 3044892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Parenteral feeding in man. Utilization and metabolic effects of parenterally administered hexoses].
    Heuckenkamp PU
    Fortschr Med; 1975 Nov; 93(32):1607-13. PubMed ID: 815147
    [No Abstract]   [Full Text] [Related]  

  • 38. [Significance of triglycerides for other metabolic parameters in the familial metabolic syndrome].
    Metzler W; Fücker K; Schwanebeck U; Hanefeld M; Julius U; Kindel B; Fischer S
    Dtsch Med Wochenschr; 2003 Sep; 128(38):1941-6. PubMed ID: 14502445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of insulin secretion by fructose ingested with protein in people with untreated type 2 diabetes.
    Gannon MC; Nuttall FQ; Grant CT; Ercan-Fang S; Ercan-Fang N
    Diabetes Care; 1998 Jan; 21(1):16-22. PubMed ID: 9538964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved insulin sensitivity by bezafibrate in rats: relationship to fatty acid composition of skeletal-muscle triglycerides.
    Matsui H; Okumura K; Kawakami K; Hibino M; Toki Y; Ito T
    Diabetes; 1997 Mar; 46(3):348-53. PubMed ID: 9032088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.